ACCESSION: MSBNK-SMB_Measured-HSA001P0213022
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 20
COMMENT: RAW_SPEC {'17_posi_10646': {'bp': 127039.0, 'sum': 397722.0}, '19_posi_11150': {'bp': 105399.0, 'sum': 363215.0}, '12_posi_10919': {'bp': 100893.0, 'sum': 368157.0}, '9_posi_10940': {'bp': 101607.0, 'sum': 390890.0}, '19_posi_11234': {'bp': 107864.0, 'sum': 414549.0}, '6_posi_11022': {'bp': 88558.0, 'sum': 339648.0}, '10_posi_10667': {'bp': 99814.0, 'sum': 360332.0}, '19_posi_10667': {'bp': 93021.0, 'sum': 373189.0}, '5_posi_11255': {'bp': 79489.0, 'sum': 285046.0}, '6_posi_11212': {'bp': 79359.0, 'sum': 299969.0}, '18_posi_11087': {'bp': 98385.0, 'sum': 368178.0}, '2_posi_10814': {'bp': 82195.0, 'sum': 304423.0}, '7_posi_10625': {'bp': 93920.0, 'sum': 364122.0}, '2_posi_11191': {'bp': 90612.0, 'sum': 385712.0}, '2_posi_11275': {'bp': 96009.0, 'sum': 330832.0}, '10_posi_10835': {'bp': 85295.0, 'sum': 351672.0}, '14_posi_11045': {'bp': 85509.0, 'sum': 326676.0}, '5_posi_11379': {'bp': 91344.0, 'sum': 361686.0}, 'ProcedureBlank_11129': {'bp': 84081.0, 'sum': 339868.0}, 'ProcedureBlank_10768': {'bp': 99993.0, 'sum': 431126.0}}
COMMENT: RETENTION_TIME_STDEV 0.480
COMMENT: PRECURSOR_M/Z_RAW 213.170589
COMMENT: PRECURSOR_M/Z_STDEV 0.000070
COMMENT: PRECURSOR_IN_MS1 mz 213.170960; int 73.059; delta(ppm) 1.073539
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+NH4; mz 230.197491; int 32.212; cor 0.687
COMMENT: PROPOSED_ION_FORM M+H; M+2ACN+H; mz 295.224073; int 13.941; cor 0.681
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+NH4; mz 189.170915; int 62.505; cor 0.623
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.132; C10H20N4O; [M+H]+; delta(ppm) -0.131974
COMMENT: PROPOSED_MF SevenGoldenRules 0.152; C8H17N3O; [M+ACN+H]+; delta(ppm) -0.151925
COMMENT: PROPOSED_MF MS-FINDER 3.626; C8H17N3O; [M+ACN+H]+; delta(ppm) 75819.505252
COMMENT: PROPOSED_MF MS-FINDER 3.113; C10H20N4O; [M+H]+; delta(ppm) -0.134735
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.255; C10H20N4O; [M+H]+; delta(ppm) -0.134735
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.255; C8H17N3O; [M+C2H3N+H]+; delta(ppm) -0.134735
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.725; C12H22NO2; [M+H]+; delta(ppm) -6.433223
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.725; C10H19O2; [M+C2H3N+H]+; delta(ppm) -6.433223
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.648; C8H18N7; [M+H]+; delta(ppm) 6.163833
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.648; C6H15N6; [M+C2H3N+H]+; delta(ppm) 6.163833
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C10H20N4O; [M+H]+; delta(ppm) -0.134735
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C8H17N3O; [M+C2H3N+H]+; delta(ppm) -0.134735
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.674; MHCILZYUJICANU-GIVGEFRWNA-N; [M+ACN+H]+; UNPD81363
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; MHCILZYUJICANU-GIVGEFRWNA-N; [M+ACN+H]+; UNPD81363
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.031; IFVRGSVHHSCKIS-UHFFFAOYSA-N; [M+ACN+H]+; N'-hydroxy-3-piperidin-1-ylpropanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.622; JJEMPZXXGBIJIX-UHFFFAOYSA-N; [M+ACN+H]+; N,N-dimethyl-2-piperazin-1-ylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.271; JNGRMEMVULIXBF-UHFFFAOYSA-N; [M+ACN+H]+; N-ethyl-4-methylpiperazine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.264; UVQCDRALXOGZQF-UHFFFAOYSA-N; [M+ACN+H]+; 2-methyl-2-piperazin-1-ylpropanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.127; AVEQCXBQACLXDJ-UHFFFAOYSA-N; [M+ACN+H]+; 4-(ethylamino)piperidine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.121; JJRVDRJMXJJPDM-UHFFFAOYSA-N; [M+ACN+H]+; N-propan-2-ylpiperazine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.028; VHKDFUCTAJWSQN-UHFFFAOYSA-N; [M+ACN+H]+; 4-(dimethylamino)piperidine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; FMLZDRMKPOUTQO-UHFFFAOYSA-N; [M+ACN+H]+; 2-(azepan-1-yl)-N'-hydroxyethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; GVZDABQVSXRGAK-UHFFFAOYSA-N; [M+ACN+H]+; N'-hydroxy-2-(2-methylpiperidin-1-yl)ethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.962; MPPMMKDXSXSUTG-UHFFFAOYSA-N; [M+ACN+H]+; 2-(4-aminopiperidin-1-yl)-N-methylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.955; WKHFGQLWQPTVJR-UHFFFAOYSA-N; [M+ACN+H]+; 2-amino-N-(1-methylpiperidin-4-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.935; SCHUXUBXKBRDDQ-UHFFFAOYSA-N; [M+ACN+H]+; 1-methyl-3-(1-methylpiperidin-4-yl)urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.929; NKIOHORMYZJSGT-UHFFFAOYSA-N; [M+ACN+H]+; 1-methyl-3-[(1-methylpyrrolidin-3-yl)methyl]urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.911; FWUDIPGDIBVLGN-UHFFFAOYSA-N; [M+ACN+H]+; 1-methyl-3-(piperidin-4-ylmethyl)urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.904; JDZQCVNSMIOFBW-UHFFFAOYSA-N; [M+ACN+H]+; N'-(1-methylpiperidin-4-yl)acetohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.887; CGPUPBFQFZRKOG-UHFFFAOYSA-N; [M+ACN+H]+; 1-[3-(dimethylamino)propyl]imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.878; SDMVZBFFDFADJN-UHFFFAOYSA-N; [M+ACN+H]+; 4-(2-hydroxyethyl)piperidine-1-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.871; QQZGDEIJFYLUIT-ZETCQYMHSA-N; [M+ACN+H]+; (2S)-1-(3-aminopropyl)pyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.640; JJQYLNCTJNLITN-UHFFFAOYSA-N; [M+ACN+H]+; 2-(dimethylamino)-1-piperazin-1-ylethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.492; CKRGUQFETZTMME-UHFFFAOYSA-N; [M+ACN+H]+; 2-(methylamino)-1-(4-methylpiperazin-1-yl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.459; OUVVCIBIGUCHRM-UHFFFAOYSA-N; [M+ACN+H]+; N,N,4-trimethylpiperazine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.323; IEXLKUJTTDIYQW-UHFFFAOYSA-N; [M+ACN+H]+; 1-[4-(2-aminoethyl)piperazin-1-yl]ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.292; HNWCTCGGYQCMQS-UHFFFAOYSA-N; [M+ACN+H]+; 3-amino-1-(4-methylpiperazin-1-yl)propan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.181; YBSDBDDIAPKFNU-UHFFFAOYSA-N; [M+ACN+H]+; 1-[2-(dimethylamino)ethyl]piperazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.170; WPFYTYMNLMYXOM-UHFFFAOYSA-N; [M+ACN+H]+; 2-amino-1-(4-ethylpiperazin-1-yl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.151; ZSKQKQLNOZOOFP-UHFFFAOYSA-N; [M+ACN+H]+; 3-amino-N,N-dimethylpiperidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.151; DPWUPATVIQFUKF-UHFFFAOYSA-N; [M+ACN+H]+; 1,1,3-trimethyl-3-pyrrolidin-3-ylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.144; QFQBCYRVCKQHGI-UHFFFAOYSA-N; [M+ACN+H]+; 1-methyl-3-[3-(methylamino)propyl]imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.144; QEHUQVCNWYOKPR-UHFFFAOYSA-N; [M+ACN+H]+; 3-[2-(dimethylamino)ethyl]-5-methylimidazolidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.120; RULVDGROGOLQOM-UHFFFAOYSA-N; [M+ACN+H]+; 2-[3-(oxolan-2-yl)propyl]guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; WHNXFFIKKJESQD-UHFFFAOYSA-N; [M+ACN+H]+; 1-(2-methylpropyl)-4-nitrosopiperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -162.498; IFVRGSVHHSCKIS; [M+C2H3N+H]+; (1-Amino-3-piperidin-1-ium-1-ylpropylidene)-hydroxyazanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -167.096; CGPUPBFQFZRKOG; [M+C2H3N+H]+; 1-[3-(Dimethylamino)propyl]imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -167.142; CKRGUQFETZTMME; [M+C2H3N+H]+; Methyl-[2-(4-methylpiperazin-4-ium-1-yl)-2-oxoethyl]azanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -169.536; JJQYLNCTJNLITN; [M+C2H3N+H]+; Dimethyl-(2-oxo-2-piperazin-1-ylethyl)azanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -173.933; IEXLKUJTTDIYQW; [M+C2H3N+H]+; 1-(4-(2-Aminoethyl)piperazin-1-yl)ethanone
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -181.687; VWJXFNNKSORGCJ; [M+H]+; N-[2-[[(cyclopropylamino)-(ethylamino)methylidene]amino]ethyl]acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -183.094; YBSDBDDIAPKFNU; [M+C2H3N+H]+; 1-[2-(Dimethylamino)ethyl]piperazin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -186.351; JJEMPZXXGBIJIX; [M+C2H3N+H]+; N,N-dimethyl-2-piperazin-1-yl-acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -192.868; OEKLURISOUYUSM; [M+H]+; 2-[[amino(propylamino)methylidene]amino]-N-(cyclopropylmethyl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -195.281; UXLUKSONJKMOMC; [M+H]+; 2-[(N-cyclopropyl-N'-methylcarbamimidoyl)amino]-N-propylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -195.479; HYNPFNJQFKWSPN; [M+H]+; 2-azido-N-octylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -196.825; PDENNAYEVKVJFD; [M+H]+; N-(cyanomethyl)-2-[4-(dimethylamino)butylamino]acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -199.388; QHEZKUMHJQLQRK; [M+H]+; 2-[[(cyclopropylamino)-(ethylamino)methylidene]amino]-N-ethylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -200.111; OXQJYVCJVWTHBO; [M+H]+; N-[2-[(N'-propylcarbamimidoyl)amino]ethyl]cyclopropanecarboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -201.666; XROAPMWCNYYQQV; [M+H]+; N-Nonylazidoformamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -204.417; YGOJSRLRINFQKD; [M+H]+; 3-(3-Piperazin-1-ylazetidin-1-yl)propanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -204.776; WCWLKDWNEQZVPL; [M+H]+; N-(4-azidobutyl)-2,2-dimethylbutanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -219.465; HNWCTCGGYQCMQS; [M+C2H3N+H]+; 3-Amino-1-(4-methylpiperazin-1-yl)propan-1-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -230.654; ZSKQKQLNOZOOFP; [M+C2H3N+H]+; [(3S)-1-(dimethylcarbamoyl)piperidin-3-yl]azanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -237.632; DPWUPATVIQFUKF; [M+C2H3N+H]+; 1,3,3-Trimethyl-1-(pyrrolidin-3-yl)urea
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.068; VWJXFNNKSORGCJ; [M+H]+; N-[2-[[(cyclopropylamino)-(ethylamino)methylidene]amino]ethyl]acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.039; IFVRGSVHHSCKIS; [M+C2H3N+H]+; (1-Amino-3-piperidin-1-ium-1-ylpropylidene)-hydroxyazanium
COMMENT: CONFIDENCE Level 5: Exact mass of interest 213.170959; Observed in MS1; Charge state Unknown;
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 22.059
MS$FOCUSED_ION: PRECURSOR_M/Z 213.170959
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-1590000000-605ff2bac56ca73844b7
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  83.0603123 49.9806 ? 83.060816 2.3357 13.65 -0.2893 15
  86.0600568 130.8627 ? 86.060524 1.1155 28.40 -0.4211 20
  97.0760462 57.9371 ? 97.076391 1.7821 11.91 -0.0343 17
  111.0916704 286.1436 ? 111.091886 0.7201 39.79 0.4090 20
  127.1107198 66.3313 ? 127.110732 2.4152 15.20 0.1113 20
  129.1023492 137.5023 ? 129.102332 1.1929 20.17 0.5143 20
  140.1182169 96.3408 ? 140.118121 2.0411 29.42 0.0836 18
  143.0816389 69.2700 ? 143.081541 1.8731 18.11 0.4294 16
  183.1129873 107.0903 ? 183.112864 1.6219 26.38 0.4030 20
  195.1604434 421.6921 ? 195.160313 1.1273 50.00 0.7203 20
  213.1422860 365.5029 ? 213.142144 3.6032 39.61 0.7338 20
  213.1711556 999.0000 ? 213.171013 0.6286 0.00 1.0000 20
  213.1905811 453.8419 ? 213.190439 0.9522 55.64 0.3444 20
PK$NUM_PEAK: 13
PK$PEAK: m/z int. rel.int.
  83.060312 49.98 49
  86.060057 130.86 130
  97.076046 57.94 57
  111.091670 286.14 286
  127.110720 66.33 66
  129.102349 137.50 137
  140.118217 96.34 96
  143.081639 69.27 69
  183.112987 107.09 107
  195.160443 421.69 421
  213.142286 365.50 365
  213.171156 999.00 999
  213.190581 453.84 453
//
